Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Primary Target
epidermal growth factor receptor
MET proto-oncogene, receptor tyrosine kinase

Indications

Mesh Heading Maximum Phase Reference
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1 ClinicalTrials
CONTENTS